Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Lawyers Ask Hepatitis C Jury to Award $2.5B

By Pharmaceutical Processing | April 9, 2013

LAS VEGAS (AP) — Plaintiffs’ attorneys asked a Nevada state court jury on Monday to put the state’s largest health management organization on the hook for a stunning $2.5 billion punitive damage award in a Las Vegas hepatitis outbreak that lawyers called the largest in U.S. history.

Lawyers Robert Eglet and Will Kemp asked the Clark County District Court civil jury on Monday to assess damages as a percentage of Health Plan of Nevada and Sierra Health Services profits to send a message to other U.S. health care corporations not to put profits ahead of patient safety.

“Pressure from Wall Street and investors causes these companies to put their profits and their shareholder profits above patient safety,” Eglet said after ending his plea to the same civil court jury that last week awarded $24 million in compensatory damages to three plaintiffs.

“Unless this jury speaks loud enough with a large punitive damages verdict, they’re not going to get the message,” Eglet said. “It’ll be business as usual.”

D. Lee Roberts Jr., attorney for the two companies, urged the jury of three men and five women not to be swayed by emotion. He referred to the results of the liability phase of the trial, which began with jury selection almost 10 weeks ago.

“An award of the magnitude, or anything close to the magnitude that plaintiffs are requesting, would be a violation of the instructions of this court and your oath as a juror,” he said.

Roberts said the jury already sent a message to his clients and corporate America, and awarding billions of dollars more as punishment would be neither “reasonable” nor “proportionate.”

“You have already made a difference,” Roberts said. “In phase one, you found that our conduct was despicable. You found fraud, malice or oppression with a conscious disregard. We understand that.”

Eglet said he calculated 15 percent of company profits to arrive at punitive damage figures of a little more than $1.9 billion from Health Plan of Nevada, and about $590,000 from Sierra Health Services. The awards would be on top of the compensatory amount last week.

Bonnie Brunson, 70, was awarded $12 million, and Helen Meyer, 76, was awarded $9 million. Each of them was infected with hepatitis C in 2005 during outpatient endoscopy procedures at a Las Vegas clinic owned by former Dr. Dipak Desai. Brunson’s husband, Carl, 72, was awarded $3 million for loss of consortium.

Health Plan of Nevada and parent company Sierra Health Services — now subsidiaries of publicly traded UnitedHealth Group Inc. — have promised to appeal.

Company lawyers argue they were prevented from showing the jury that company executives didn’t know when they certified Desai as a network physician about complaints that Desai was endangering patients with unsafe endoscopy practices, including boasts that he performed the fastest colonoscopies in the country.

Roberts argued that Desai was responsible for the hepatitis outbreak, not the companies.

Desai, once a powerful member of the state Board of Medical Examiners, wasn’t named in the civil lawsuit. He has denied wrongdoing, declared bankruptcy and surrendered his medical license, but faces trial in state court later this month and federal court next month on separate criminal charges stemming from the outbreak.

Desai’s lawyers have fought for years to prove that he is so incapacitated by strokes and other physical ailments that he is unfit for trial, but state prosecutors accuse him of faking his medical conditions in an attempt to escape prosecution.

Eglet told the jury Monday that after the hepatitis outbreak became public in early 2008, the Southern Nevada Health District in Las Vegas notified some 63,000 people that they were at risk for blood-borne diseases including AIDS and should be tested.

Health investigators later traced hepatitis C infections of nine people to procedures conducted in 2007 at Desai’s endoscopy clinics. Although investigators reported finding hepatitis C in another 105 patients, the cases weren’t conclusively linked to Desai clinics.

Eglet and Kemp also won hundreds of millions of dollars in civil judgments in 2011 against pharmaceutical companies they blamed for supplying recklessly large vials of the powerful anesthetic propofol to Desai clinics. Jurors were told in that case that the large vials were unsafely reused from patient to patient.

Desai and his clinics reached undisclosed settlements with plaintiffs before trial in those cases.

_____

Find Ken Ritter on Twitter: http://twitter.com/krttr

 

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE